Evidence map›Paper›PMID 41600912›Full record

ArticleViruses2025

Correction: de Melo et al. SARS-CoV-2 Spike Protein and Long COVID-Part 1: Impact of Spike Protein in Pathophysiological Mechanisms of Long COVID Syndrome.

Bruno Pereira de Melo, Jhéssica Adriane Mello da Silva, Mariana Alves Rodrigues, Julys da Fonseca Palmeira, Felipe Saldanha-Araujo, Gustavo Adolfo Argañaraz, Enrique Roberto Argañaraz

Abstract readPublished Erratum
In one paragraph

Article in Viruses, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Bruno Pereira de MeloLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0009-0003-7222-429X
Jhéssica Adriane Mello da SilvaLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0009-0001-7566-3496
Mariana Alves RodriguesLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0009-0001-0595-5880
Julys da Fonseca PalmeiraLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0000-0002-2724-369X
Felipe Saldanha-AraujoLaboratory of Hematology and Stem Cells (LHCT), Faculty of Health Sciences, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0000-0002-4200-0821
Gustavo Adolfo ArgañarazLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0000-0002-1612-2411
Enrique Roberto ArgañarazLaboratory of Molecular Neurovirology, Department of Pharmacy, Faculty of Health Science, University of Brasília, Brasilia 70910-900, DF, Brazil.ORCID 0000-0002-4359-7594

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41600912
PMCPMC12846426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.